Tofersen
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Tofersen, covering 2024-06-10 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study of BIIB067 (Tofersen) Initiated in Clinically Presymptomatic Adults With a Confirmed Superoxide Dismutase 1 Mutation [Phase 3]